Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic area in Bangladesh by Khan, Md  Gulam Musawwir et al.
SHORT REPORT Open Access
Evaluation of rK-39 strip test using urine for
diagnosis of visceral leishmaniasis in an endemic
area in Bangladesh
Md Gulam Musawwir Khan
1, Mohammad Shafiul Alam
1*, Milka Patracia Podder
2, Makoto Itoh






Diagnosis of visceral leishmaniasis (VL) by demonstration of parasites in tissue smears obtained from bone marrow,
spleen or lymph nodes is risky, painful, and difficult. The rK-39 strip test is widely used for the diagnosis of VL using
blood/serum samples in endemic countries. The aim of the study was to evaluate the rK-39 strip test using urine
sample as a non-invasive means for the diagnosis of VL. The rk-39 strip test was performed using urine from 100
suspected VL cases along with 25 disease control (malarial febrile cases) and 50 healthy control (from endemic and
non-endemic areas). All the VL suspected cases were positive with the rK-39 strip test using serum. The sensitivity
and specificity of the rK-39 strip test using urine samples was 95% and 93.3%, respectively, compared to serum
based rK-39 test. The findings suggest that the urine based rK-39 test could be a practical and efficient tool for the
diagnosis of VL patients in rural areas, particularly where resources are limited.
Introduction
Visceral leishmaniasis (VL) is a serious public health
problem in Bangladesh where 20 million people (18% of
the total population) are at risk with a trend of rising
incidence [1]. Diagnosis of VL still relies on clinical
manifestations and microscopic confirmation of para-
sites from aspirates of lymph nodes, bone marrow, and
t h es p l e e n .T h e s ei n v a s i v ea n dp a i n f u lt e c h n i q u e s
require skilled personnel and are difficult to implement
in resource-limited settings. Several less-invasive serolo-
gical tests, including indirect fluorescent antibody test
(IFAT), enzyme-linked immunosorbent assay (ELISA),
and an improved version of direct agglutination test
(DAT) have been evaluated for the diagnosis of VL
[2-4]. However, a rapid immune-chromatographic test
(ICT) based on a recombinant 39-amino acid repeat
antigen, conserved in the kinesin region of Leishmania
chagasi and Leishmania donovani (rK-39 strip test),
gained popularity for the field screening of kala-azar [5].
The detection of soluble antigen and antibody in urine
of VL patients has been reported [6]. A urine-based
ELISA method has also been developed to detect anti-
Leishmania donovani immunoglobulin G (IgG) [7].
Recently, a low molecular weight, heat-stable, and car-
bohydrate based leishmanial antigen has also been
detected in urine of VL patients [8]. A latex agglutina-
tion test (KAtex) based on antigen detection in urine of
VL cases has been evaluated in different field studies;
however, the test showed lower sensitivity in some stu-
dies [9,10]. So, the antibody detection tests especially
DAT and rK-39 strip test, are still being extensively
used in the field-screening of VL.
The study was conducted to determine the potential
application of the rK-39 strip test for detecting anti-
leishmanial antibody in urine for the preliminary diag-
nosis of VL infection compared with the serum-based
rK-39 test to establish the value of the urine-based rapid
test for the primary diagnosis of VL.
Study area and population
In total, 100 suspected VL patients, who were positive
w i t ht h es e r u mb a s e dr K - 3 9s t r i pt e s ta n dh a df e v e rf o r
at least two weeks, along with other clinical signs [11],
were enrolled in this study from Trishal Upazila (sub-
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which is one of the most endemic VL regions in Bangla-
desh. All the VL subjects were treated free of charge in
the UHC as per the National Guideline and the WHO
recommendations. To investigate cross-reaction with
other diseases, twenty five (25) subjects with malaria
were enrolled from a malaria-endemic area. To investi-
gate subclinical infection, twenty five (25) healthy con-
trols were enrolled who lived in the endemic area
(Trishal) but did not have a past history of VL. Twenty
five (25) healthy controls from non-endemic area were
also enrolled for assessing the specificity of the urine
rK-39 strip test. The serum rK-39 test was performed
again in the field setting, a small laboratory in Trishal
with that is near about 300 meters form UHC, whereas
the urine rK-39 test was performed in the Parasitology
Laboratory, ICDDR,B in Dhaka.
Ethical approval
The Ethical Review Committee (ERC) and Research
Review Committee (RRC) of ICDDR,B approved the
study.
Sample collection and methods
Finger- prick blood was taken in a capillary tube and
transferred to a micro-tube (200 μm). Urine samples
were also collected in a tube containing preservative
(Na-azide) and stored at 4°C until transporting to the
ICDDR,B. The blood sample was then centrifuged for
separation of serum at the field laboratory (Trishal)
where the rK-39 strip test (Kalaazar Detect™, InBios Inc.,
USA) was also performed as per the protocol of the
manufacturer. Briefly, 1 drop of serum samples was
applied to the base of nitro-cellulose strips impregnated
with recombinant rK-39 antigen. After being air-dried, 3
drops of the test buffer (phosphate-buffered saline, plus
bovine serum albumin) were added, and the strip was
placed upright. The appearance of a lower red band
(control) indicated the proper functioning of the test
while the appearance of an upper red band indicated
the presence of anti-rK-39 IgG, signifying a positive test.
For urine assay, 3 drops of urine sample were applied
directly to the strip without adding any test buffer. In
both the cases the strip was observed after 10 minutes
for the test band. A skilled laboratory technician per-
formed the urine rK-39 strip test in the Parasitology
Laboratory ICDDR,B who also monitored the serum rK-
39 strip test at the field level.
Data analysis
Sensitivity and specificity were computed along with
95% confidence interval (CI) using the Epi Info software
(version 6.02; CDC, Atlanta, GA, USA). Data were also
analyzed by 2×2 contingency tables using the SPSS
software (version 10.0) for Windows (release 10.0.1,
standard version, 1999; SPSS Inc., Chicago, USA), which
enabled us to calculate the kappa coefficient or  value.
Reproducibility was assessed between the field rK-39
serum test and the urine rK-39 test in laboratory set-
tings followed by Landis Koch [12] based on  value.
Results
The serum rK-39 strip test was positive in 100 enrolled
VL subjects whereas all the healthy controls from the
endemic area and non-endemic area and all the diseased
controls (confirmed malaria subjects) were tested nega-
tive. The urine rK-39 strip test was positive in 95 out of
the 100 VL subjects and in five out of 25 confirmed
malaria patients who were tested negative in serum rK-
39 strip test. However, the urine rK-39 was tested nega-
tive in all the healthy controls from the VL endemic and
non-endemic areas. Thus, the sensitivity and specificity
of urine rK-39 was found 95% (95% CI: 88.2-98.1) and
93.3% (95% CI: 84.5-97.5), respectively, considering the
s e r u mr K - 3 9t e s tr e s u l ta st h eg o l ds t a n d a r d( T a b l e1 ) .
Kappa coefficient () for the urine rK-39 strip test was
found 0.88.
Discussion
According to the national guideline for the treatment of
VL in Bangladesh, suspected kala-azar cases must be
confirmed by a positive rK-39 or demonstration of para-
site in the tissue (bone marrow/splenic puncture) or by
PCR [11]. The ICT based rK-39 antibody test has been
used widely in Bangladesh for the diagnosis of VL
because of its high sensitivity and specificity [5].
According to the instruction of the manufacturer, this
test is performed using serum or plasma for which col-
lection of venous blood or figure- prick is necessary. But
our study showed an excellent sensitivity and specificity
level for the rK-39 dipstick test using a non-invasive
procedure, i.e. urine samples. The sensitivity of the
urine rK-39 strip test observed in our study (95%) cor-
roborates the results of the urine-based DAT (90.7%)
Table 1 Comparison of urine and Serum based rK-39
strip test in the diagnosis of clinically suspected VL




+ve -ve +ve -ve
No. of VL case 100 0 95 5
No. of Malaria 0 25 5 20
No. of Non endemic healthy control 0 25 0 25
No. of VL Endemic healthy control 0 25 0 25
Total 100 75 100 75
Urine rK-39 strip sensitivity: 95% (95% CI: 88.2-98.1); specificity: 93.3% (95% CI:
84.5-97.5); kappa (): 0.88
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city of urine rK-39 in our study is within the acceptance
level of the serum rK-39 strip test’s sensitivity and speci-
ficity of specificity targeted (>90%) in the Indian subcon-
tinent [13]. The urine-based rK-39 test has great
advantages over the serum-based test because of ease of
sample collection without causing any discomfort or
pain to the subject. The non-invasive urine collection
procedure minimizes the risk of blood-borne infections
and facilitates the collection of samples from infants and
children. Although, in our study a considerable number
of positive test result with malaria (5/25) were noted in
urine rK-39 test, but none was found in the healthy
control subjects. We suspect this positive urine rK-39
strip test as false-positive as they were tested negative in
the serum rk-39 test in the same malaria patient. This
kind of false positivity might be raised due to the bind-
ing of unknown urinary components with the rK-39
antigen line in the test strip. According to Boelaert et
al. [14], an ideal VL rapid diagnostic test should achieve
a sensitivity level of ≥95% and a specificity level of ≥98%
in both field and laboratory settings, and the test results
should be interpreted in 30 minutes. The findings of
our study showed that the non-invasive urine rK-39
strip test gave results in 10 minutes. The sensitivity of
our test was satisfactory; however desired specificity was
not achieved. The reproducibility of the urine rK-39
strip test was excellent ( = 0.88) which corroborates
with the reproducibility that had been assessed in a
multi-centre evaluation of rK39 strip test with serum
conducted in East Africa and the Indian subcontinent
[13].
In our study the specificity has probably been overes-
timated because under real-life conditions there will be
many malaria patients among the suspects to be tested.
Moreover, half of the healthy controls were from a
non-endemic area. The sensitivity may have been over-
estimated in our study because the comparison was
based on rK-39 sero-positive subjects. Another limita-
tion of the rK-39 test is its variable sensitivity and spe-
cificity reported in different studies [15-18]. To
overcome these limitations, further investigations are
required to assess the performance of the urine rK-39
test in a larger field condition with a larger population
size, including parasitological confirmed VL subjects to
confirm our data.
Conclusion
The urine rK-39 strip test would be a promising non-
invasive point-of-care tool for the rapid screening of VL
in remote rural areas where there is a high prevalence
of VL. However, a large scale field evaluation of the
urine rK-39 strip test is required before using it as a
diagnostic tool for VL patients in different endemic
areas. To the best of our knowledge, this is the first
study on rK-39 strip test using urine samples.
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